Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-01-28 18:00 |
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2019
|
English | 286.0 KB | ||
| 2019-01-28 18:00 |
THERANEXUS PUBLIE SON AGENDA FINANCIER 2019
|
French | 294.0 KB | ||
| 2019-01-04 18:00 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 2nd SEMESTRE 2018
|
French | 271.4 KB | ||
| 2018-12-14 08:00 |
THERANEXUS ANNONCE L'ARRIVÉE DE MONSIEUR JÉRÔME MARTINEZ AU SEIN DE SON CONSEIL…
|
French | 271.0 KB | ||
| 2018-12-14 08:00 |
THERANEXUS ANNOUNCES APPOINTMENT OF JEROME MARTINEZ TO ITS BOARD OF DIRECTORS
|
English | 316.7 KB | ||
| 2018-05-22 08:00 |
THERANEXUS ANNOUNCES THE PUBLICATION OF A SCIENTIFIC ARTICLE ON THE MECHANISM O…
|
English | 261.3 KB | ||
| 2018-05-22 08:00 |
THERANEXUS ANNONCE LA PUBLICATION D'UN ARTICLE SCIENTIFIQUE SUR LE MECANISME D'…
|
French | 273.3 KB | ||
| 2018-05-15 18:00 |
THERANEXUS PUBLISHES ITS CASH POSITION AS AT 31 MARCH 2018
|
English | 203.1 KB | ||
| 2018-05-15 18:00 |
THERANEXUS PUBLIE SA POSITION DE TRESORERIE AU 31 MARS 2018
|
French | 260.8 KB | ||
| 2018-05-07 07:30 |
Theranexus presentation at the International Connexins Symposium (Vancouver 14-…
|
English | 313.7 KB | ||
| 2018-05-07 07:30 |
Présentation de THERANEXUS au Symposium international sur les connexines (Vanco…
|
French | 318.6 KB | ||
| 2018-05-02 07:30 |
ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AN…
|
English | 278.6 KB | ||
| 2018-05-02 07:30 |
PRÉSENTATION ORALE DE THERANEXUS LORS DU 9ÈME CONGRÈS EUROPÉEN SUR LA NARCOLEPS…
|
French | 284.1 KB | ||
| 2018-04-27 18:00 |
MISE À DISPOSITION DU DOCUMENT DE RÉFÉRENCE 2017
|
French | 249.2 KB | ||
| 2018-04-23 07:30 |
THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTR…
|
English | 754.4 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
